LHLyen C. Huang

Lyen C. Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lyen C. Huang has a total of 306 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dietary Patterns Associated With Weight Loss Among Patients With Colorectal Cancer During the First 6 Months After Diagnosis: A Cross-Sectional Analysis From the ColoCare Study

    by Rachel Hoobler, Fred K. Tabung, Tengda Lin, Biljana Gigic, Kristen S. Smith, Kary Woodruff, Sylvia L. Crowder, Sheetal Hardikar, Doratha A. Byrd, Adriana M. Coletta, et al.

  • The people left behind

    by Lyen C. Huang, Kevin D. Helling


  • Open Access

    Proto‐Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer

    by Donghyun Kim, Saima Sharif, Juan Antonio Raygoza Garay, Avanish S. Bhakta, Patrick M. Boland, Michael J. Cavnar, Michelle L. Churchman, Hassan Hatoum, Lyen C. Huang, Joseph Kim, et al.

    Background: Mutational landscape is prognostic in colorectal cancer (CRC). Rat sarcoma ( RAS ) oncogenes, such as KRAS and NRAS , with driver mutations, portend poor survival outcomes, whereas pathologic mutations in HRAS are extremely rare, and their prognostic value remains uncertain. Methods: This retrospective study analyzed the Oncology Research Information Exchange Network (ORIEN) alliance tumor RNA‐Seq data in Stages II and III CRC to investigate the association between RAS gene expression and survival outcomes. Results: High transcript levels of HRAS were associated with superior overall survival (OS). The high HRAS ‐associated OS benefit was most pronounced in patients with right‐sided primary expressing low KRAS transcript levels in the absence of pathologic KRAS mutations. Conclusions: Contrary to the notion that RAS family genes are proto‐oncogenic, this study demonstrates that high HRAS transcript levels are associated with superior OS in Stages II and III CRC. The potential of HRAS as a prognostic biomarker should be explored further.


  • Evaluating a health system‐wide opioid disposal intervention distributing home‐disposal bags

    by Lyen C. Huang, Josh Bleicher, Michael Torre, Jordan E. Johnson, Angela Presson, Morgan M. Millar, Adam J. Gordon, Benjamin S. Brooke, Kimberly A. Kaphingst, Alex H. S. Harris

    ObjectiveTo evaluate a health system-wide intervention distributing free home-disposal bags to surgery patients prescribed opioids.Data Sources and Study SettingWe collected patient surveys and electronic medical record data at an academic health system.Study DesignWe conducted a prospective observational study. The bags were primarily distributed at pharmacies, though pharmacists delivered bags to some patients. The primary outcome was disposal of leftover opioids (effectiveness). Secondary outcomes were patient willingness to dispose and factors associated with disposal (effectiveness), recalling receipt of the bag (reach), and recalling receipt of bags and disposal over time (maintenance). We used a modified Poisson regression to evaluate the relative risk of disposal. Inverse probability of treatment weighting, based on propensity scores, was used to account for differences between survey responders and non-responders and reduce nonresponse bias.Data Collection/Extraction MethodsFrom August 2020 to May 2021, we surveyed patients 2 weeks after discharge (allowing for home opioid use). Eligibility criteria were age & GE;18, English being primary language, valid email address, hospitalization & LE;30 days, discharge home, and an opioid prescription sent to a system pharmacy.Principal FindingsWe identified 5134 patients with 2174 completing the survey (response rate 42.3%). Among respondents, 1375 (63.8%) recalled receiving the disposal bag. Among 1075 respondents with leftover opioids, 284 (26.4%) disposed, 552 (51.3%) planned to dispose, 79 (7.4%) did not plan to dispose, 69 (6.4%) had undecided, and 91 (8.5%) had not considered disposal. Recalling receipt of the bag (incidence rate ratio [IRR] 1.25, 95% confidence interval [CI] 1.13-1.37) was positively associated with disposal. Patients who used opioids in the last year were less likely to dispose (IRR 0.82, 95% CI 0.73-0.93). Disposal rates remained stable over the study period while recalling receipt of bags trended up.ConclusionsA pragmatic implementation of a disposal intervention resulted in lower disposal rates than prior trials.


  • Open Access

    Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study

    by Lyen C. Huang, Henry Nibley, Melissa Cheng, Josh Bleicher, Hyunkyu Ko, Jordan E. Johnson, Marta L. McCrum


  • Open Access

    Supplementary Data from Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients

    by Caroline Himbert, Christy A. Warby, Biljana Gigic, Jennifer Ose, Tengda Lin, Richard Viskochil, Anita R. Peoples, Anjelica Ashworth, Petra Schrotz-King, Courtney L. Scaife, et al.

    Supplementary Data from Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients

  • Open Access

    Supplementary Data from Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients

    by Caroline Himbert, Christy A. Warby, Biljana Gigic, Jennifer Ose, Tengda Lin, Richard Viskochil, Anita R. Peoples, Anjelica Ashworth, Petra Schrotz-King, Courtney L. Scaife, et al.

    Supplementary Data from Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients

  • Surgical Trainee Perspectives on the Opioid Crisis: The Influence of Explicit and Hidden Curricula

    by Josh Bleicher, Jordan E. Johnson, Brian T. Cain, Robert D. Shaw, Alexandra A. Acher, Lauren Gleason, Richard J. Barth, Daniel I. Chu, Sarah Jung, David Melnick, et al.


  • Open Access

    Patient Willingness to Dispose of Leftover Opioids After Surgery

    by Phoebe Draper, Josh Bleicher, Jaqueline K. Bs Kobayashi, Elizabeth L. Bs Stauder, Gregory J. Mba Stoddard, Jordan E. Ches Johnson, Jessica N. Md Cohan, Kimberly A. ScD Kaphingst, Alex H. S. Harris, Lyen C. Md Huang

    Objectives: We examined how convenience and financial incentives influence patient willingness to dispose of leftover prescription opioids after surgery. We also identified additional barriers and facilitators to disposal. Background: In the United States, up to 70% of surgical patients are prescribed opioids and up to 92% will have leftover tablets. Most do not dispose of leftover opioids, increasing the risk for opioid-related harm. Current interventions promoting opioid disposal have shown mixed success. Methods: We conducted a mixed methods study using a standard gamble survey and semi-structured interviews. Participants estimated willingness to dispose in 16 scenarios with varying convenience (time requirements of <5, 15, 30, and 60 minutes) and financial incentives ($0, $5, $25, $50). We estimated the likelihood of disposal using a multivariable mixed effects modified Poisson regression model. Semi-structured interviews explored how convenience, financial incentives, and other barriers and facilitators influenced decisions to dispose. Results: Fifty-five participants were surveyed and 42 were interviewed. Most were willing to dispose when the time required was <15 minutes. Few were willing to dispose if the process required 60 minutes, although a $50 financial incentive increased rates from 9% to 36%. Anxiety about future pain, opioid scarcity, recreational use, family safety, moral beliefs, addiction, theft, and environmental harm also influenced decision-making. Conclusions: Interventions promoting opioid disposal should focus on convenience, but the selective use of financial incentives can be effective. Tailoring interventions to individual barriers and facilitators could also increase disposal rates.


  • Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients

    by Caroline Himbert, Christy A. Warby, Biljana Gigic, Jennifer Ose, Tengda Lin, Richard Viskochil, Anita R. Peoples, Anjelica Ashworth, Petra Schrotz-King, Courtney L. Scaife, et al.

    Background: Physical activity and obesity are well-established factors of colorectal cancer risk and prognosis. Here, we investigate associations of individual and combined physical activity and body mass index (BMI) groups with proinflammatory biomarkers in colorectal cancer patients. Methods: Self-reported physical activity levels were classified as “active” (≥8.75 MET-hours/week) versus “inactive” (<8.75 MET-hours/week) in n = 579 stage I–IV colorectal cancer patients enrolled in the ColoCare Study. BMI [normal weight (≥18.5–<25 kg/m2), overweight (≥25–<30 kg/m2), and obese (≥30 kg/m2)] was abstracted from medical records. Patients were classified into four combinations of physical activity levels and BMI. Biomarkers [C-reactive protein (CRP), SAA, IL6, IL8, and TNFα] in presurgery serum samples were measured using the Mesoscale Discovery Platform. Regression models were used to compute relative percent differences in biomarker levels by physical activity and BMI groups. Results: “Inactive” patients had non-statistically significant higher IL6 levels compared with “active” patients (+36%, P = 0.10). “Obese” patients had 88% and 17% higher CRP and TNFα levels compared with “normal weight” patients (P = 0.03 and 0.02, respectively). Highest CRP levels were observed among “overweight or obese/inactive” compared with “normal weight/active” patients (P = 0.03). Conclusions: We provide evidence of associations between individual and combined physical activity and BMI groups with proinflammatory biomarkers. Although BMI was identified as the key driver of inflammation, biomarker levels were higher among “inactive” patients across BMI groups. Impact: This is the largest study in colorectal cancer patients investigating associations of energy balance components with inflammatory biomarkers. Our results suggest that physical activity may reduce obesity-induced inflammation in colorectal cancer patients and support the design of randomized controlled trials testing this hypothesis.